PBE · Invesco Biotechnology & Genome ETF ETF
$97.64
-1.08 (-1.10%)
At close · Sep 4
Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.
Holders: 1
Total Value: $448,160
Total Shares: 4,999
Institutional Ownership Trend
22 quarters
Holder Concentration
Across 1 13F filers · Δ vs Sep 30, 2025Top Holder
100.0%
0.0 pts
Top 5
100.0%
0.0 pts
Top 10
100.0%
0.0 pts
HHI
10,000
Highly concentrated0
Quarterly Activity
vs Sep 30, 2025
New
1
Increased
0
Decreased
0
Sold Out
1
Unchanged
0
Holder count:
0
Institutional value:
+100.4%
Shares held:
+56.2%
Top New Positions
vs Sep 30, 2025| Institution | Acquired | Value (USD) | Open |
|---|---|---|---|
| Mega CITADEL ADVISORS LLC | 4,999 | $448,160 |
Top Sold-Out Positions
vs Sep 30, 2025| Institution | Previously Held | Last Value (USD) | Open |
|---|---|---|---|
| Mid Dakota Wealth Management | 3,200 | $223,584 |
| Holder | Value (USD) | % of 13F | Shares | Type | Filed | Open |
|---|---|---|---|---|---|---|
| Mega CITADEL ADVISORS LLC PBE | $448,160 | 100.00% | 4,999 | Shares | 2026-09-02 |